Simbrinza Interactions
There are 377 drugs known to interact with Simbrinza (brimonidine/brinzolamide ophthalmic), along with 10 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 8 are major, and 369 are moderate.
- View all 377 medications that may interact with Simbrinza
- View Simbrinza alcohol/food interactions (1)
- View Simbrinza disease interactions (10)
Most frequently checked interactions
View interaction reports for Simbrinza (brimonidine / brinzolamide ophthalmic) and the medicines listed below.
- albuterol
- amlodipine
- aspirin
- atorvastatin
- azelastine nasal
- biotin
- calcium / vitamin d
- Coenzyme Q10 (ubiquinone)
- Eliquis (apixaban)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- furosemide
- gabapentin
- latanoprost ophthalmic
- levothyroxine
- lisinopril
- losartan
- Lumigan (bimatoprost ophthalmic)
- metformin
- omeprazole
- pantoprazole
- prednisone
- rosuvastatin
- timolol ophthalmic
- tramadol
- Travatan Z (travoprost ophthalmic)
- turmeric
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zyrtec (cetirizine)
Simbrinza alcohol/food interactions
There is 1 alcohol/food interaction with Simbrinza (brimonidine / brinzolamide ophthalmic).
Simbrinza disease interactions
There are 10 disease interactions with Simbrinza (brimonidine / brinzolamide ophthalmic) which include:
- hematologic toxicity
- hypersensitivity reactions
- porphyria
- cardiovascular
- depression
- renal/liver
- crystalluria
- liver disease
- renal dysfunction
- urinary obstruction
Report options
More about Simbrinza (brimonidine / brinzolamide ophthalmic)
- Simbrinza consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (28)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: ophthalmic glaucoma agents
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.